| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/26/1993 | US5182301 Diphenylethylene derivatives pharmaceutical compositions containing same and treatment methods |
| 01/26/1993 | US5182300 Furosemide salts |
| 01/26/1993 | US5182299 Myo-inositol or sorbitol |
| 01/26/1993 | US5182297 Thienylhaloallylamines |
| 01/26/1993 | US5182296 Naphthyloxazolidone derivatives |
| 01/26/1993 | US5182294 Imidazolyl propyl guanidine derivative and a pharmaceutical composition containing this compound |
| 01/26/1993 | US5182293 Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones |
| 01/26/1993 | US5182288 Substituted n-biphenylyl lactams |
| 01/26/1993 | US5182285 Cell-protective composition for preventing or treating of peptic ulcer |
| 01/26/1993 | US5182283 Alzheimer's disease |
| 01/26/1993 | US5182281 (omega-(4-(2-pyrimidinyl)-1-piperazinyl)alkyl)-1h-azole derivatives for the treatment of disorders of cognitive functions |
| 01/26/1993 | US5182280 Derivatives of benzimidazole and their use as antihistamines |
| 01/26/1993 | US5182279 Benzothienopyrazinedione compounds and their preparation and use |
| 01/26/1993 | US5182276 Nootropic agent |
| 01/26/1993 | US5182274 Nonionic surfactant, citric acid or tartaric acid chelating agent |
| 01/26/1993 | US5182273 Spirocyclic n, o derivatives of cyclotriphosphazenes and their use in therapy |
| 01/26/1993 | US5182272 8-substituted-dibenz[b,f][1,4]oxazepine-10(11)-carboxylic acid, substituted hydrazides, pharmaceutical compositions, and methods for treating pain |
| 01/26/1993 | US5182271 Thioether, keto-ester and alkyl phospholipids useful in treating multiple sclerosis |
| 01/26/1993 | US5182270 Stabilizing preparation for thymoxamine |
| 01/26/1993 | US5182268 Pharmaceutical composition comprising daunorubicin potentiated with 2,4,5-tri (4-methoxyphenyl)-4,5-dihydroimidazole |
| 01/26/1993 | US5182267 Microemulsion containing vegetable oil or triglyceride and N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine malate |
| 01/26/1993 | US5182112 Antidiarrheal compositions containing laperamide hydrochloride and a saccharide |
| 01/26/1993 | US5182106 Method for treating hypothermia |
| 01/26/1993 | US5182104 Topical virucidal composition for treatment of mucocutaneous tissue |
| 01/26/1993 | US5182103 Magnesium aluminometasilicate coated composite powder and use thereof |
| 01/26/1993 | US5182102 Mixture of a miotic and a beta-blocker, reduction of aqueous humor formation and improved outflow of humor |
| 01/26/1993 | US5182097 Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
| 01/26/1993 | CA2074605A1 Therapeutic amides |
| 01/26/1993 | CA2072680A1 Substituted cyclopropylamino-1,3,5-triazines |
| 01/26/1993 | CA1313189C Immunomodulatory azaspiranes |
| 01/26/1993 | CA1313155C Antibiotic compounds and their preparation |
| 01/26/1993 | CA1313141C Macrophage stimulation by quadrol |
| 01/26/1993 | CA1313140C Pharmaceutical composition containing cimetidine |
| 01/26/1993 | CA1313139C D1-5-[(2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl] thiazolidine-2,4-dione as an anti-atherosclerosis agent |
| 01/26/1993 | CA1313138C Method for alleviation of primary depressive disorders |
| 01/26/1993 | CA1313137C Method of inhibiting interleukin-1 activity |
| 01/26/1993 | CA1313136C Cough/cold mixtures comprising non-sedating antihistamine drugs |
| 01/26/1993 | CA1313135C Cholestyramine composition and process for its preparation |
| 01/26/1993 | CA1313134C Endogenous growth hormone |
| 01/26/1993 | CA1313132C Coating membrane and compositions prepared therefrom |
| 01/25/1993 | CA2074568A1 Dimethyl acetoacetamides, process for their preparation and pharmaceuticals |
| 01/25/1993 | CA2074420A1 Cyclohexane and tetrahydropyran derivatives |
| 01/25/1993 | CA2074051A1 Seed treatment |
| 01/25/1993 | CA2073913A1 Preparation of fatty acid medicaments |
| 01/24/1993 | WO1993001804A1 Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
| 01/24/1993 | CA2074328A1 Process for the 14a-hydroxylation of avermectin compounds |
| 01/24/1993 | CA2074216A1 Topical anti-fungal agents having anti-inflammatory activity |
| 01/24/1993 | CA2070495A1 Substituted 3,4-dihydronaphthalenes, pharmaceutical compositions containing these compounds and processes for the preparation of these compounds and compositions |
| 01/23/1993 | CA2074211A1 Arylalkylamine derivatives |
| 01/23/1993 | CA2073488A1 Benzo (a) fluorene compounds |
| 01/21/1993 | WO1993001496A1 Method for detecting and distinguishing between cobalamin and folic acid deficiency based on amino acid assay |
| 01/21/1993 | WO1993001281A1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 01/21/1993 | WO1993001202A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 01/21/1993 | WO1993001201A1 Mono and bis alkylamino-anthracyclines |
| 01/21/1993 | WO1993001198A1 Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories |
| 01/21/1993 | WO1993001197A1 Derivatives of inositol, preparations containing them and their use |
| 01/21/1993 | WO1993001195A1 DIBENZ[b,e]AZEPINE DERIVATIVES AND DRUGS CONTAINING THEM |
| 01/21/1993 | WO1993001192A1 2-(2-substituted pyrrolidinylthio)carbapenem derivatives |
| 01/21/1993 | WO1993001190A1 Novel 2-amino naphthyridine derivative, its preparation and use |
| 01/21/1993 | WO1993001189A1 Method for preparating optical isomers of a 2-amino naphthyridine derivative |
| 01/21/1993 | WO1993001188A1 Method for preparing optical isomers of a 2-amino naphthyridine derivative |
| 01/21/1993 | WO1993001187A1 Process for the preparation of a dextrogyral isomer of an isoindolinone derivative |
| 01/21/1993 | WO1993001186A1 Hydroisoquinoline derivatives |
| 01/21/1993 | WO1993001182A1 Methylen-oxindole derivatives and process for their preparation |
| 01/21/1993 | WO1993001181A1 Substituted indoles as anti-aids pharmaceuticals |
| 01/21/1993 | WO1993001177A1 Substituted triazolinones |
| 01/21/1993 | WO1993001175A1 14-O-p-CHLOROBENZOYLACONINE AND ANALGESIC/ANTIINFLAMMATORY AGENT |
| 01/21/1993 | WO1993001170A1 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/21/1993 | WO1993001169A2 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | WO1993001167A1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same |
| 01/21/1993 | WO1993001165A2 Aromatic compounds, compositions containing them and their use in therapy |
| 01/21/1993 | WO1993001163A1 Amino acid derivative |
| 01/21/1993 | WO1993001160A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | WO1993000939A1 Pharmaceutical preparation for peritoneal dialysis |
| 01/21/1993 | WO1993000932A1 Method of reversing local anesthesia and reagent system therefor |
| 01/21/1993 | WO1993000929A1 Novel compositions based on taxane class derivatives |
| 01/21/1993 | WO1993000928A1 Novel compositions based on taxane class derivatives |
| 01/21/1993 | WO1993000927A1 Cancer treatment |
| 01/21/1993 | WO1993000919A1 Compositions and methods for inhibiting leukocyte adhesion to cns myelin |
| 01/21/1993 | WO1993000915A1 Colestipol hydrochloride high-content tablets |
| 01/21/1993 | WO1993000914A1 Metabolizable plasma substitute |
| 01/21/1993 | WO1993000913A1 Use of natamycin for the treatment and prevention of poultry mycosis |
| 01/21/1993 | WO1993000910A1 Antiviral liponucleosides: treatment of hepatitis b |
| 01/21/1993 | WO1993000909A1 Method and assay system for neurotrophin activity |
| 01/21/1993 | WO1993000908A1 Elam-1 receptor ligands as diagnostic compounds |
| 01/21/1993 | WO1993000905A1 Tropical composition containing penciclovir |
| 01/21/1993 | WO1993000904A1 Dihydropyrimido-quinoxalines and dihydropyrimido-pyridopyrazines useful for treating tumours |
| 01/21/1993 | WO1993000903A1 Use of substituted pyridazines against dermatosis |
| 01/21/1993 | WO1993000902A1 Apoptosis regulator |
| 01/21/1993 | WO1993000900A1 1,2-dihydro-8-piperazinyl-4-phenylimidazopyridopyrazine oxides and 1,2-dihydro-8-piperazinyl-4 phenylimidazoquinoxaline oxides useful for treating tumors |
| 01/21/1993 | WO1993000899A1 Use of 3-(3-pyridyl) 1h,3h-pyrrolo[1,2-c]thiazole 7-carboxamide for treating retroviral infections |
| 01/21/1993 | WO1993000898A1 Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof |
| 01/21/1993 | WO1993000897A1 Cholecystokinin antagonists useful in the treatment of panic attacks |
| 01/21/1993 | WO1993000896A1 Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse |
| 01/21/1993 | WO1993000895A1 Analgesic |
| 01/21/1993 | WO1993000894A1 Prostaglandin e2 treatment of impotence |
| 01/21/1993 | WO1993000893A1 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 01/21/1993 | WO1993000892A1 Pharmaceutical preparation |
| 01/21/1993 | WO1993000891A1 Enzyme-sensitive enteric preparation for oral administration |
| 01/21/1993 | WO1993000889A1 METHOD FOR THE PREPARATION OF PROLONGED-RELEASE ORAL PHARMACEUTICAL FORMS CONTAINING ACTIVE SUBSTANCES HAVING A SOLUBILITY DEPENDENT UPON THE pH VALUE |